What is VALACYCLOVIR HYDROCHLORIDE used for?

VALACYCLOVIR HYDROCHLORIDE (brand name Valacyclovir Hydrochloride) is a Antiviral (Herpes) indicated for papule, vesicle, papule.

How does VALACYCLOVIR HYDROCHLORIDE work?

VALACYCLOVIR HYDROCHLORIDE works through the following mechanism: 12.1 Mechanism of Action Valacyclovir is an antiviral drug active against α-herpes viruses [see Microbiology (12.4) ] ..

What are the most common side effects of VALACYCLOVIR HYDROCHLORIDE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for VALACYCLOVIR HYDROCHLORIDE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is VALACYCLOVIR HYDROCHLORIDE the same as Valacyclovir Hydrochloride?

Valacyclovir Hydrochloride is a brand name for VALACYCLOVIR HYDROCHLORIDE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

VALACYCLOVIR HYDROCHLORIDE

Antiviral (Herpes)

Brand names: Valacyclovir Hydrochloride

Oral

Mechanism of Action

12.1 Mechanism of Action Valacyclovir is an antiviral drug active against α-herpes viruses [see Microbiology (12.4) ] .

Indications

papule

vesicle

papule

vesicle

Contraindications

• 4 CONTRAINDICATIONS Valacyclovir tablets are contraindicated in patients who have had a demonstrated clinically significant hypersensitivity reaction (e.g.
• anaphylaxis) to valacyclovir
• acyclovir
• or any component of the formulation [see Adverse Reactions (6.3) ] . Hypersensitivity to valacyclovir (e.g.
• anaphylaxis)

FDA Warnings

5 WARNINGS AND PRECAUTIONS Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): Has occurred in patients with advanced HIV-1 disease and in allogenic bone marrow transplant and renal transplant patients receiving 8 grams per day of valacyclovir hydrochloride in clinical trials
1 Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS) TTP/HUS, in some cases resulting in death, has occurred in patients with advanced HIV-1 disease and also in allogeneic bone marrow transplant and renal transplant recipients participating in clinical trials of valacyclovir hydrochloride at doses of 8 grams per day

Known Side Effects

11 documented side effects by frequency

Fatigue

1-10%

Drug Not Working

1-10%

Nausea

1-10%

Diarrhea

1-10%

Headache

1-10%

Fever

1-10%

Rash

1-10%

Dizziness

1-10%

Shortness of Breath

0.1-1%

Vomiting

0.1-1%

Weakness

0.1-1%

Community Discussions

No community discussions found for VALACYCLOVIR HYDROCHLORIDE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → VALACYCLOVIR HYDROCHLORIDE openFDA label JSON → VALACYCLOVIR HYDROCHLORIDE FAERS adverse-event reports → VALACYCLOVIR HYDROCHLORIDE ClinicalTrials.gov → completed Phase 2+ trials of VALACYCLOVIR HYDROCHLORIDE

Compare With

4 available comparisons

Formulations

Dosage Forms

Tablet

Route

Oral